Does BOSUTINIB Cause Tumour marker increased? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Tumour marker increased have been filed in association with BOSUTINIB (BOSULIF). This represents 0.2% of all adverse event reports for BOSUTINIB.
17
Reports of Tumour marker increased with BOSUTINIB
0.2%
of all BOSUTINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Tumour marker increased From BOSUTINIB?
Of the 17 reports, 3 (17.6%) required hospitalization.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which BOSUTINIB Alternatives Have Lower Tumour marker increased Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE